Literature DB >> 8259801

The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits.

J P Struewing1, K C Hyams, J E Tueller, G C Gray.   

Abstract

OBJECTIVES: To assess the risk of epidemic transmission and to guide immunization policy, the seroprevalence of antibody to measles, mumps, and varicella was determined in a group of young adults.
METHODS: A cross-sectional study of 1533 US Navy and Marine Corps recruits was conducted in June 1989. Antibody status was determined with commercially available enzyme-linked immunosorbent assays.
RESULTS: Direct sex and race adjustment to the 15- to 29-year-old US population resulted in seronegativity rates of 17.8% for measles, 12.3% for mumps, and 6.7% for varicella. Measles and mumps seronegativity rates were higher among Whites whereas varicella seronegativity was higher among non-Whites. Recruits enlisting from outside the 50 US states, especially those from island territories, were more likely to lack varicella antibody. The sensitivity of a positive history of vaccination or disease in predicting antibody status was less than 90% for all diseases.
CONCLUSIONS: These results suggest a continued potential for epidemics, especially of measles, and the need for mandatory immunization policies. Immigrants to the United States, especially those from island territories, may be a high-risk group that could benefit from varicella vaccination.

Mesh:

Substances:

Year:  1993        PMID: 8259801      PMCID: PMC1694921          DOI: 10.2105/ajph.83.12.1717

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  29 in total

1.  COMPARISONS BETWEEN CHICKENPOX IN A TROPICAL AND A EUROPEAN COUNTRY.

Authors:  Z MARETIC; M P COORAY
Journal:  J Trop Med Hyg       Date:  1963-12

2.  Immunity status of military recruits in 1951 in the United States. II. Results of mumps complement-fixation tests.

Authors:  S J LIAO; A S BENENSON
Journal:  Am J Hyg       Date:  1954-05

3.  Increasing incidence of varicella hospitalizations in United States Army and Navy personnel: are today's teenagers more susceptible? Should recruits be vaccinated?

Authors:  G C Gray; L A Palinkas; P W Kelley
Journal:  Pediatrics       Date:  1990-12       Impact factor: 7.124

4.  Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test.

Authors:  P Larussa; S Steinberg; E Waithe; B Hanna; R Holzman
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

5.  Brief report: susceptibility of Filipino nurses to the varicella-zoster virus.

Authors:  N T Nassar; H C Touma
Journal:  Infect Control       Date:  1986-02

6.  Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status.

Authors:  P W Neumann; J M Weber; A G Jessamine; M V O'Shaughnessy
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

7.  Epidemiological standardization of a test for susceptibility to mumps.

Authors:  Z M Shehab; P A Brunell; E Cobb
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

8.  Assessment of susceptibility to measles and rubella.

Authors:  S R Preblud; F Gross; N A Halsey; A R Hinman; K L Herrmann; J P Koplan
Journal:  JAMA       Date:  1982-02-26       Impact factor: 56.272

9.  Perspectives on the relative resurgence of mumps in the United States.

Authors:  S L Cochi; S R Preblud; W A Orenstein
Journal:  Am J Dis Child       Date:  1988-05

10.  Continuing measles transmission in students despite school-based outbreak control program.

Authors:  S G Wassilak; W A Orenstein; P L Strickland; C A Butler; K J Bart
Journal:  Am J Epidemiol       Date:  1985-08       Impact factor: 4.897

View more
  5 in total

1.  Varicella vaccine in pregnancy.

Authors:  D S Seidman; D K Stevenson; A M Arvin
Journal:  BMJ       Date:  1996-09-21

2.  Validity of medical record documented varicella-zoster virus among unvaccinated cohorts.

Authors:  Salini Mohanty; Dana Perella; Aisha Jumaan; Donovan Robinson; Christine M Forke; D Scott Schmid; Mia Renwick; Foram Mankodi; Barbara Watson; Alexander G Fiks
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

3.  Varicella susceptibility in a Canadian population.

Authors:  S Ratnam
Journal:  Can J Infect Dis       Date:  2000-09

4.  Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002.

Authors:  Gustavo H Dayan; María S Panero; Roberto Debbag; Ana Urquiza; Marta Molina; Susana Prieto; María Del Carmen Perego; Graciela Scagliotti; Diana Galimberti; Guillermo Carroli; Cristina Wolff; D Scott Schmid; Vladimir Loparev; Dalya Guris; Jane Seward
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 5.  Postherpetic neuralgia in the cancer patient.

Authors:  E Lojeski; R A Stevens
Journal:  Curr Rev Pain       Date:  2000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.